| Authors | Andrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, Cosimo Martino, Fortunato Ciardiello, Silvia Marsoni, Salvatore Siena |
| Journal | JAMA oncology
(JAMA Oncol)
Vol. 6
Issue 6
Pg. 927-929
(06 01 2020)
ISSN: 2374-2445 [Electronic] United States |
| PMID | 32324210
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study)
|
| Chemical References |
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Lapatinib
- ERBB2 protein, human
- Receptor, ErbB-2
- Trastuzumab
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(therapeutic use)
- Central Nervous System Neoplasms
(radiotherapy, secondary, surgery)
- Colorectal Neoplasms
(drug therapy, metabolism, mortality, pathology)
- Drug Resistance, Neoplasm
- Female
- Humans
- Lapatinib
(therapeutic use)
- Male
- Middle Aged
- Protein Kinase Inhibitors
(therapeutic use)
- Receptor, ErbB-2
(metabolism)
- Recurrence
- Trastuzumab
(therapeutic use)
- Treatment Outcome
|
